Nov 4 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 350 mln 271 mln 800 mln
(+29.2 pct) (-4.9 pct) (+11.5 pct)
Operating loss 97 mln loss 109 mln loss 180 mln
Recurring loss 108 mln loss 106 mln loss 180 mln
Net loss 111 mln loss 39 mln loss 190 mln
EPS loss 15.37 yen loss 6.05 yen loss 28.14 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))